What is the current recommended management of hepatocellular carcinoma with macrovascular invasion and well-preserved liver function?
Fuente:
Zenodo
Saved in:
| Main Author: | |
|---|---|
| Format: | Recurso digital |
| Published: |
Zenodo
2026
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1866901796272734208 |
|---|---|
| author | Tripdatabase |
| author_facet | Tripdatabase |
| contents | Management of hepatocellular carcinoma with macrovascular invasion and well-preserved liver function includes systemic therapies like nivolumab plus ipilimumab and anlotinib plus penpulimab, as well as locoregional approaches like TARE and combined TACE therapies. Treatment is chosen based on individual assessments and multidisciplinary discussions. |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_19578590 |
| institution | Zenodo |
| language | |
| publishDate | 2026 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | What is the current recommended management of hepatocellular carcinoma with macrovascular invasion and well-preserved liver function? Tripdatabase hepatocellular carcinoma macrovascular invasion liver function cancer management oncology gastroenterology liver cancer treatment guidelines Management of hepatocellular carcinoma with macrovascular invasion and well-preserved liver function includes systemic therapies like nivolumab plus ipilimumab and anlotinib plus penpulimab, as well as locoregional approaches like TARE and combined TACE therapies. Treatment is chosen based on individual assessments and multidisciplinary discussions. |
| title | What is the current recommended management of hepatocellular carcinoma with macrovascular invasion and well-preserved liver function? |
| topic | hepatocellular carcinoma macrovascular invasion liver function cancer management oncology gastroenterology liver cancer treatment guidelines |
| url | https://doi.org/10.5281/zenodo.19578590 |